Thomas, McNerney & Partners
Overview
Thomas, McNerney & Partners is a health care venture capital firm with approximately $600 million under management focused on investing in
Investment Focus
- Focus on life science and medical technology sectors
- Interest in companies at all stages of development
- Preference for investments in the United States
Portfolio Companies
Reach Thomas, McNerney & Partners directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Thomas, McNerney & Partners
What sectors does Thomas, McNerney & Partners invest in?
Thomas, McNerney & Partners invests in Pharmaceuticals, Medical Devices, Diagnostics, Biotechnology and Medical Equipment, and is based in Stamford, Connecticut, United States. Thomas, McNerney & Partners is listed as a vc in the ConnectSafely investor database.
What stage does Thomas, McNerney & Partners invest at?
Thomas, McNerney & Partners backs companies at Seed, Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 5M - 40M.
Which regions does Thomas, McNerney & Partners invest in?
Thomas, McNerney & Partners invests across United States.
What companies has Thomas, McNerney & Partners invested in?
Thomas, McNerney & Partners's portfolio includes Altair Therapeutics, Inc., American Medical Systems Holdings, Inc., Coley Pharmaceutical Group, Inc., The Medicines Company, NeXagen, Inc., OsteoBiologics, Inc., Oxford GlycoSciences, plc and Transkaryotic Therapies, Inc..
How do I contact Thomas, McNerney & Partners?
Thomas, McNerney & Partners's contact details — including work email, phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
